Work

Supplementary Table from Phase II Trial of Dasatinib in Patients with Metastatic Breast Cancer Using Real-Time Pharmacodynamic Tissue Biomarkers of Src Inhibition to Escalate Dosing

Year: 2023

Type: supplementary-materials

Abstract: XLS file - 16K, Pulmonary and pleural effusions, pneumonitis.

DOI: 10.1158/1078-0432.22444086

Authors: Christina I. Herold, Vijaya Chadaram, Bercedis L. Peterson, P. Kelly Marcom, Judith Hopkins, Gretchen G. Kimmick, Justin Favaro, Erika Hamilton, Renee A. Welch, Sarah Bacus, Kimberly L. Blackwell

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361881241

Cites:

Cited by:

Related to: 10